Peripheral artery disease and genetics: Is there a cause-and-effect relationship?

Postgraduate Medicine

Volumn 122, Issue 4, 2010, Pages 170-176

  Chi, Yung Wei ^a   Jaff, Michael R ^b,c  

^a OCHSNER CLINIC FOUNDATION   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Ankle brachial index; Genetic associations; Peripheral artery disease

Indexed keywords

BLOOD CLOTTING FACTOR 13A; BLOOD CLOTTING FACTOR 7; CHLOROPHYLL; CYTOKINE RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GELATINASE B; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; INTERSTITIAL COLLAGENASE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PORPHYRIN; PROTHROMBIN; VITAMIN K GROUP;

ANKLE BRACHIAL INDEX; ARTICLE; CALCIUM SIGNALING; CARDIOVASCULAR RISK; DIABETES MELLITUS; DISEASE ASSOCIATION; EXTRACELLULAR MATRIX; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HEMODYNAMICS; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INFLAMMATION; MORBIDITY; MORTALITY; PATHOGENESIS; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PROTEIN INTERACTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SMOKING; THROMBOPHILIA; GENETIC MARKER; PATHOPHYSIOLOGY; PERIPHERAL VASCULAR DISEASE; REVIEW; RISK FACTOR;

ANKLE BRACHIAL INDEX; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; PERIPHERAL VASCULAR DISEASES; RISK FACTORS;

EID: 77956639878     PISSN: 00325481     EISSN: 19419260     Source Type: Journal    
DOI: 10.3810/pgm.2010.07.2183     Document Type: Article

References (48)

1. Hiatt WR. Medical treatment of peripheral arterial disease and claudication. N Engl J Med. 2001;344(21):1608-1621.
2. Hiatt WR, Hoag S, Hamman RF. Effect of diagnostic criteria on the prevalence of peripheral arterial disease. The San Luis Valley Diabetes Study. Circulation. 1995;91(5):1472-1479.
3. Pearson TA, Manolio TA. How to interpret a genome-wide association study. JAMA. 2008;299(11):1335-1344. Erratum in: JAMA. 2008;299(18):2150.
4. Newman B, Selby JV, King MC, Slemenda C, Fabsitz R, Friedman GD. Concordance for type 2 (non-insulin-dependent) diabetes mellitus in male twins. Diabetologia. 1987;30(10):763-768.
5. Carmelli D, Robinette D, Fabsitz R. Concordance, discordance and prevalence of hypertension in World War II male veteran twins. J Hypertens. 1994;12(3):323-328.
6. Murabito JM, Guo CY, Fox CS, D'Agostino RB. Heritability of the ankle-brachial index: the Framingham Offspring study. Am J Epidemiol. 2006;164(10):963-968.
7. Kullo IJ, Turner ST, Kardia SL, Mosley TH Jr, Boerwinkle E, de Andrade M. A genome-wide linkage scan for ankle-brachial index in African American and non-Hispanic white subjects participating in the GENOA study. Atherosclerosis. 2006;187(2):433-438.
8. Allison MA, Criqui MH, McClelland RL, et al. The effect of novel cardiovascular risk factors on the ethnic-specific odds for peripheral arterial disease in the Multi-Ethnic Study of Atherosclerosis (MESA). J Am Coll Cardiol. 2006;48(6):1190-1197.
9. Valentine RJ, Verstraete R, Clagett GP, Cohen JC. Premature cardiovascular disease is common in relatives of patients with premature peripheral atherosclerosis. Arch Intern Med. 2000;160(9):1343-1348.
10. Carmelli D, Fabsitz RR, Swan GE, Reed T, Miller B, Wolf PA. Contribution of genetic and environmental influences to ankle-brachial blood pressure index in the NHLBI Twin Study. National Heart, Lung, and Blood Institute. Am J Epidemiol. 2000;151(5):452-458.
11. Kuller L, Borhani N, Furberg C, et al. Prevalence of subclinical atherosclerosis and cardiovascular disease and association with risk factors in the Cardiovascular Health Study. Am J Epidemiol. 1994;139(12): 1164-1179.
12. O'Donnell CJ, Cupples LA, D'Agostino RB, et al. Genome-wide association study for subclinical atherosclerosis in major arterial territories in the NHLBI's Framingham Heart Study. BMC Med Genet. 2007;8(suppl 1):S4.
13. Fabsitz RR, Kalousdian S, Carmelli D, Robinette D, Christian JC. Characteristics of participants and nonparticipants in the NHLBI Twin Study. Acta Genet Med Gemellol (Roma). 1988;37(3-4):217-228.
14. Strong JP, Richards ML. Cigarette smoking and atherosclerosis in autopsied men. Atherosclerosis. 1976;23(3):451-476.
15. Haapanen A, Koskenvuo M, Kaprio J, Kesäniemi YA, Heikkilä K. Carotid arteriosclerosis in identical twins discordant for cigarette smoking. Circulation. 1989;80(1):10-16.
16. Thorgeirsson T, Geller F, Sulem P, et al. A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature. 2008;452(7187):638-641.
17. Hirsch AT, Haskal ZJ, Hertzer NR, et al; American Association for Vascular Surgery/Society for Vascular Surgery; Society for Cardiovascular Angiography and Interventions; Society for Vascular Medicine and Biology; Society of Interventional Radiology; ACC/ AHA Task Force on Practice Guidelines. ACC/AHA Guidelines for the Management of Patients with Peripheral Arterial Disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Associations for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (writing committee to develop guidelines for the management of patients with peripheral arterial disease)-summary of recommendations. J Vasc Interv Radiol. 2006;17(9):1383-1397.
18. Signorelli SS, Mazzarino MC, Spandidos DA, Malaponte G. Proinflammatory circulating molecules in peripheral arterial disease. Int J Mol Med. 2007;20(3):279-286.
19. Clark AG. The role of haplotypes in candidate gene studies. Genet Epidemiol. 2004;27(4):321-333.
20. Knowles JW, Assimes TL, Li J, Quertermous T, Cooke JP. Genetic susceptibility to peripheral arterial disease: a dark corner in vascular biology. Arterioscler Thromb Vasc Biol. 2007;27(10):2068-2078.
21. Mueller T, Marschon R, Dieplinger B, et al. Factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations are not associated with chronic limb ischemia: the Linz Peripheral Arterial Disease (LIPAD) study. J Vasc Surg. 2005;41(5):808-815.
22. Renner W, Köppel H, Brodmann M, et al. Factor II G20210A and factor V G1691A gene mutations and peripheral arterial occlusive disease. Thromb Haemost. 2000;83(1):20-22.
23. Reny JL, Alhenc-Gelas M, Fontana P, et al. The factor II G20210A gene polymorphism, but not factor V Arg506Gln, is associated with peripheral arterial disease: results of a case-control study. J Thromb Haemost. 2004;2(8):1334-1340.
24. Sofi F, Lari B, Rogolino A, et al. Thrombophilic risk factors for symptomatic peripheral arterial disease. J Vasc Surg. 2005;41(2):255-260.
25. Lee AJ, Fowkes FG, Lowe GD, Connor JM, Rumley A. Fibrinogen, factor VII and PAI-1 genotypes and the risk of coronary and peripheral atherosclerosis: Edinburgh Artery Study. Thromb Haemost. 1999;81(4):553-560.
26. Renner W, Brodmann M, Pabst E, Stanger O, Wascher TC, Pilger E. The V34L polymorphism of factor XIII and peripheral arterial disease. Int Angiol. 2002;21(1):53-57.
27. Sabino A, Fernandes AP, Lima LM, et al. Polymorphism in the methylenetetrahydrofolate reductase (C677T) gene and homocysteine levels: a comparison in Brazilian patients with coronary arterial disease, ischemic stroke and peripheral arterial obstructive disease. J Thromb Thrombolysis. 2009;27(1):82-87.
28. Todesco L, Angst C, Litynski P, Loehrer F, Fowler B, Haefeli WE. Methylenetetrahydrofolate reductase polymorphism, plasma homocysteine and age. Eur J Clin Invest. 1999;29(12):1003-1009.
29. Renner W, Brodmann M, Winkler M, Washer TC, Pilger E. The PLA1/A2 polymorphism of platelet glycoprotein IIIa is not associated with peripheral arterial disease. Thromb Haemost. 2001;85(4):745-746.
30. Smith FB, Connor JM, Lee AJ, et al. Relationship of the platelet glycoprotein PlA and fibrinogen T/G+1689 polymorphisms with peripheral arterial disease and ischaemic heart disease. Thromb Res. 2003;112(4):209-216.
31. Smadja DM, Loriot MA, Hindorff LA, Mellottee L, Gaussem P, Emmerich J. No clear link between VKORC1 genetic polymorphism and the risk of venous thrombosis or peripheral arterial disease. Thromb Haemost. 2008;99(5):970-972.
32. Fowkes FG, Lee AJ, Hau CM, Cooke A, Connor JM, Lowe GD. Methylene tetrahydrofolate reductase (MTHFR) and nitric oxide synthase (ecNOS) genes and risks of peripheral arterial disease and coronary heart disease: Edinburgh Artery Study. Atherosclerosis. 2000;150(1):179-185.
33. Renner W, Pabst E, Paulweber B, et al. The angiotensin-converting-enzyme insertion/deletion polymorphism is not a risk factor for peripheral arterial disease. Atherosclerosis. 2002;165(1):175-178.
34. Taute BM, Handschug K, Taute R, Seifert H, Gläser C, Podhaisky H. Angiotensin-converting enzyme gene insertion/deletion polymorphism and peripheral arterial occlusive disease. Vasa. 1998;27(3):149-153.
35. Baar Y, Salmayenli N, Aksoy M, Seçkin S, Aydin M, Ozkök E. ACE gene polymorphism in peripheral vascular disease. Horm Metab Res. 2007;39(7):534-537.
36. Karagiannis A, Balaska K, Tziomalos K, et al. Lack of an association between angiotensin converting enzyme gene polymorphism and peripheral arterial occlusive disease. Vasc Med. 2004;9(3):189-192.
37. Li R, Nicklas B, Pahor M, et al. Polymorphisms of angiotensinogen and angiotensin-converting enzyme associated with lower extremity arterial disease in the Health, Aging and Body Composition study. J Hum Hypertens. 2007;21(8):673-682.
38. Schillinger M, Exner M, Mlekusch W, et al. Heme oxygenase-1 gene promoter polymorphism is associated with abdominal aortic aneurysm. Thromb Res. 2002;106(2):131-136.
39. Danielsson P, Truedsson L, Eriksson KF, Norgren L. Inflammatory markers and IL-6 polymorphism in peripheral arterial disease with and without diabetes mellitus. Vasc Med. 2005;10(3):191-198.
40. Flex A, Gaetani E, Pola R, et al. The-174 G/C polymorphism of the interleukin-6 gene promoter is associated with peripheral artery occlusive disease. Eur J Vasc Endovasc Surg. 2002;24(3):264-268.
41. Flex A, Gaetani E, Angelini F, et al. Pro-inflammatory genetic profiles in subjects with peripheral arterial occlusive disease and critical limb ischemia. J Intern Med. 2007;262(1):124-130.
42. Potaczek DP, Undas A, Nowakowski T, Szczeklik A. Association between inflammatory markers and the interleukin-6-174 G/C polymorphism is abolished in peripheral arterial occlusive disease. Int Angiol. 2007;26(4):318-323.
43. Gugl A, Renner W, Seinost G, et al. Two polymorphisms in the fractalkine receptor CX3CR1 are not associated with peripheral arterial disease. Atherosclerosis. 2003;166(2):339-343.
44. Ghilardi G, Biondi ML, Battaglioli L, Zambon A, Guagnellini E, Scorza R. Genetic risk factor characterizes abdominal aortic aneurysm from arterial occlusive disease in human beings: CCR5 Delta 32 deletion. J Vasc Surg. 2004;40(5):995-1000.
45. Renner W, Schallmoser K, Gallippi P, et al. C242T polymorphism of the p22 phox gene is not associated with peripheral arterial occlusive disease. Atherosclerosis. 2000;152(1):175-179.
46. Gaetani E, Flex A, Pola R, et al. The K469E polymorphism of the ICAM-1 gene is a risk factor for peripheral arterial occlusive disease. Blood Coagul Fibrinolysis. 2002;13(6):483-488.
47. Jones GT, Phillips VL, Harris EL, Rossaak JI, van Rij AM. Functional matrix metalloproteinase-9 polymorphism (C-1562T) associated with abdominal aortic aneurysm. J Vasc Surg. 2003;38(6):1363-1367.
48. Catalano M, Cortelazzo A, Santi R, et al. The Pro12Ala polymorphism of peroxisome proliferator-activated receptor-gamma2 gene is associated with plasma levels of soluble RAGE (Receptor for Advanced Glycation Endproducts) and the presence of peripheral arterial disease. Clin Biochem. 2008;41(12):981-985.